- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Bristol-Myers Squibb Co
+ Add to WatchlistBMY:US
46.4900 USD 0.4400 0.94%As of 12:37:52 ET on 10/03/2013.
Snapshot for Bristol-Myers Squibb Co (BMY)
| Open: | 46.7800 | Day's Range: | 46.1400 - 46.9300 | Volume: | 2,338,829 |
|---|---|---|---|---|---|
| Previous Close: | 46.9300 | 52wk Range: | 30.6400 - 49.5700 | 1-Yr Rtn: | +43.36% |
Key Statistics for BMY
| Current P/E Ratio (ttm) | 28.5443 |
|---|---|
| Estimated P/E(12/2013) | 26.5823 |
| Relative P/E vs. SPX | 1.7677 |
| Earnings Per Share (USD) (ttm) | 1.6185 |
| Est. EPS (USD) (12/2013) | 1.7380 |
| Est. PEG Ratio | 2.8219 |
| Market Cap (M USD) | 76,060.16 |
| Shares Outstanding (M) | 1,646.32 |
| 30 Day Average Volume | 6,934,850 |
| Price/Book (mrq) | 5.2978 |
| Price/Sale (ttm) | 4.8300 |
| Dividend Indicated Gross Yield | 3.03% |
| Cash Dividend (USD) | 0.3500 |
| Dividend Ex-Date | 10/02/2013 |
| 5 Year Dividend Growth | 2.46% |
| Next Earnings Announcement | 10/23/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BMY
Company Profile & Key Executives for BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
| Lamberto AndreottiChief Executive Officer | Francis CussChief Scientific Officer |
| Louis S SchmuklerPres:Global Manufacturing | Giovanni CaforioPres:US Pharmaceuticals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
Advertisement
-
BMY News
-
Industry News
Advertisement
Sponsored Links
Advertisements
Rate this Page